LifeStance Health Group (NASDAQ:LFST) Stock Price Expected to Rise, BTIG Research Analyst Says

LifeStance Health Group (NASDAQ:LFST) had its price objective raised by equities researchers at BTIG Research from $12.00 to $15.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. BTIG Research’s target price indicates a potential upside of 37.61% from the stock’s current price.

A number of other equities research analysts have also weighed in on the stock. JPMorgan Chase & Co. upped their target price on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock a “neutral” rating in a report on Thursday, May 14th. Barclays increased their price objective on LifeStance Health Group from $9.00 to $13.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 14th. Wall Street Zen upgraded LifeStance Health Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 4th. KeyCorp lifted their target price on LifeStance Health Group from $11.00 to $13.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. Finally, Canaccord Genuity Group upped their price target on LifeStance Health Group from $11.00 to $13.00 and gave the stock a “buy” rating in a report on Tuesday, July 21st. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, LifeStance Health Group has an average rating of “Moderate Buy” and a consensus price target of $11.50.

LifeStance Health Group Stock Performance

NASDAQ LFST opened at $10.90 on Friday. The company has a fifty day simple moving average of $9.33 and a 200 day simple moving average of $7.82. LifeStance Health Group has a 12-month low of $3.74 and a 12-month high of $11.76. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.18. The company has a market cap of $4.23 billion, a P/E ratio of 181.67 and a beta of 1.12.

LifeStance Health Group (NASDAQ:LFST) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.04 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.03. LifeStance Health Group had a net margin of 1.55% and a return on equity of 1.56%. The firm had revenue of $403.48 million for the quarter, compared to the consensus estimate of $387.46 million. The business’s revenue was up 21.2% on a year-over-year basis. Sell-side analysts predict that LifeStance Health Group will post 0.12 earnings per share for the current fiscal year.

Insider Buying and Selling at LifeStance Health Group

In related news, Director Eric Shuey sold 243,362 shares of the business’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $8.02, for a total value of $1,951,763.24. Following the sale, the director directly owned 867,562 shares in the company, valued at approximately $6,957,847.24. The trade was a 21.91% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Darren M. Black sold 5,899,661 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $8.02, for a total transaction of $47,315,281.22. Following the completion of the sale, the director directly owned 23,310,115 shares in the company, valued at approximately $186,947,122.30. This trade represents a 20.20% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 7,687,394 shares of company stock worth $63,579,701 over the last ninety days. 3.50% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On LifeStance Health Group

Several hedge funds and other institutional investors have recently added to or reduced their stakes in LFST. Larson Financial Group LLC increased its holdings in shares of LifeStance Health Group by 19,952.6% in the 4th quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock worth $27,000 after buying an additional 3,791 shares during the last quarter. KBC Group NV bought a new stake in shares of LifeStance Health Group during the 1st quarter worth $29,000. EverSource Wealth Advisors LLC lifted its holdings in shares of LifeStance Health Group by 359.1% during the 1st quarter. EverSource Wealth Advisors LLC now owns 6,909 shares of the company’s stock worth $44,000 after acquiring an additional 5,404 shares during the last quarter. PNC Financial Services Group Inc. grew its position in LifeStance Health Group by 615.3% in the first quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company’s stock worth $59,000 after acquiring an additional 7,987 shares in the last quarter. Finally, Assetmark Inc. grew its position in LifeStance Health Group by 17.0% in the first quarter. Assetmark Inc. now owns 9,419 shares of the company’s stock worth $60,000 after acquiring an additional 1,367 shares in the last quarter. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.